(19)
(11) EP 4 551 245 A1

(12)

(43) Date of publication:
14.05.2025 Bulletin 2025/20

(21) Application number: 23738510.9

(22) Date of filing: 04.07.2023
(51) International Patent Classification (IPC): 
A61K 38/42(2006.01)
A61P 3/00(2006.01)
A61P 25/14(2006.01)
C07K 14/47(2006.01)
A61K 48/00(2006.01)
A61P 25/00(2006.01)
C12N 15/86(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 48/0075; A61K 38/42; A61P 25/14; A61P 25/00; A61P 3/00; C12N 15/86; C12N 2750/14143; C12N 2840/203; A61K 48/005; C07K 14/805
(86) International application number:
PCT/EP2023/068369
(87) International publication number:
WO 2024/008709 (11.01.2024 Gazette 2024/02)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
KH MA MD TN

(30) Priority: 05.07.2022 EP 22306002

(71) Applicants:
  • Institut National de la Santé et de la Recherche Médicale (INSERM)
    75013 Paris (FR)
  • Association Française contre les Myopathies (A.F.M.)
    75013 Paris (FR)
  • Université Paris Cité
    75006 Paris (FR)

(72) Inventors:
  • CORRAL-DEBRINSKI, Marisol
    75019 PARIS (FR)
  • GRESSENS, Pierre
    75019 PARIS (FR)

(74) Representative: Plasseraud IP 
104 Rue de Richelieu CS92104
75080 Paris Cedex 02
75080 Paris Cedex 02 (FR)

   


(54) INTRAVENOUS ADMINISTRATION OF NEUROGLOBIN FOR TREATING NEUROLOGICAL DISORDERS